(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DEEP CYCLIC INHIBITION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DEEP CYCLIC INHIBITION

ST13

US500000097937383

Class

5, 42, 44

Filing

97937383

Registration

7646006

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

01/29/2025

Trademark type

Word

Nice classes

5, 42, 44

Filing date

05/15/2023

Registration date

01/07/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/07/2025

Last transaction

01/29/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

12/07/2023

First use in commerce

12/07/2023

Drawing code

4

Owner type

03

Owner location

Cambridge, MA

Examiner

OAKES, ANNA

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

I. C. (pessoa física)

Representatives

Ian W. Gillies KNOBBE MARTENS OLSON & BEAR, LLP

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

chemical preparations and reagents for pharmaceuticalmedicalclinical purposes; pharmaceuticalspharmaceutical preparations and substances developed with a computer software platform using biology and chemistry analytics for use in the prevention and treatment of cancer and oncological diseases and disorders; pharmaceuticalspharmaceutical preparations and substances for the prevention and treatment of cancer and oncological diseases and disorders

Class 42

pharmaceutical research and development; providing scientific information in the fields of pharmaceuticalsbiologychemistrybiochemistrybiotechnologyclinical trials; providing medical research and scientific research information in the fields of pharmaceuticalsbiologychemistrybiochemistrybiotechnologyclinical trials via the internet; research and development of new products

Class 44

providing medical information in the fields of pharmaceuticalsbiologychemistrybiochemistrybiotechnologyclinical trials; providing medical information in the fields of pharmaceuticalsbiologychemistrybiochemistrybiotechnologyclinical trials via the internet

Publications

History of USPTO decisions and trademark events.

37 publications found

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/07/2025

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

01/07/2025

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

12/11/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/20/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/20/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/20/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/03/2024

GNRT

NON-FINAL ACTION E-MAILED

09/03/2024

CNRT

NON-FINAL ACTION WRITTEN

09/03/2024

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

07/26/2024

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

06/11/2024

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

05/28/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

05/28/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/28/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

05/28/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/28/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/16/2024

GNRT

NON-FINAL ACTION E-MAILED

05/16/2024

CNRT

NON-FINAL ACTION WRITTEN

05/16/2024

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

04/19/2024

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

03/19/2024

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

03/05/2024

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

03/04/2024

IUAA

USE AMENDMENT ACCEPTED

03/04/2024

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

01/06/2024

IUAF

USE AMENDMENT FILED

01/06/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/05/2024

EAAU

TEAS AMENDMENT OF USE RECEIVED

01/05/2024

DOCK

ASSIGNED TO EXAMINER

10/26/2023

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

10/04/2023

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

10/04/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/06/2023

GNRT

NON-FINAL ACTION E-MAILED

07/06/2023

CNRT

NON-FINAL ACTION WRITTEN

07/06/2023

DOCK

ASSIGNED TO EXAMINER

07/05/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/14/2023

NWAP

NEW APPLICATION ENTERED

05/18/2023

Continuous trademark protection

Get notified about every new filing that threatens DEEP CYCLIC INHIBITION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.